Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a terminated Phase 2 feasibility study with minimal enrollment (n=7) that did not complete, assessing device wear adherence as the primary endpoint rather than clinical efficacy; no results are reported in this registry record.
This is a pilot feasibility and acceptability trial not yet recruiting, with no results posted; it measures process outcomes and explores preliminary efficacy signals in cancer-related cognitive impairment.